Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What CAGR Is Anticipated for the Cardiac Biomarkers Testing Market Through 2029?

Recent years have seen rapid expansion in the cardiac biomarkers testing market, with its size anticipated to rise from $13.48 billion in 2024 to $14.95 billion by 2025, marking an impressive compound annual growth rate (CAGR) of 10.9%. Growth observed in the historic period seems to be driven by a variety of factors including a rise in cardiovascular disease, an aging demographic, enhanced awareness and education efforts, government strategies and healthcare policies, as well as an uptick in healthcare spending.

In the coming years, a swift expansion is projected for the cardiac biomarkers testing market, with a size anticipated to reach $23.24 billion by 2029, propelled by a compound annual growth rate (CAGR) of 11.7%. Factors contributing to this advancement during the forecast timeframe include the implementation of personalized medicine, the escalating global prevalence of cardiovascular disorders, the assimilation of artificial intelligence (AI) within diagnostic procedures, the enlargement of point-of-care testing, and a growing emphasis on the early detection of illnesses. The market is also likely to see trends that include technological progressions, the development of AI-assisted diagnostics, an increase in point-of-care testing (POCT), advancements in multiplexing abilities, and progress in the discovery and validation of biomarkers.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

What Market Forces Are Driving The Cardiac Biomarkers Testing Sector In 2025 And Beyond?

The surge in occurrences of cardiovascular illnesses is anticipated to fuel the expansion of the cardiac biomarkers testing market in the future. Cardiovascular disease encompasses any condition impacting the heart or blood vessels. Testing for cardiac biomarkers aids in promptly assessing biomarker levels to determine the gravity of a heart attack and its extent. Consequently, a rise in cardiovascular disease cases increases the demand for cardiac biomarker testing solutions. For example, the American College of Cardiology, a professional medical organization based in the US, predicted in August 2022 that there would be a significant increase in cardiovascular risk factors and disease in the country by 2060. Hence, the rising incidence of cardiovascular diseases is propelling the growth of the cardiac biomarkers testing market.

How Is The Global Cardiac Biomarkers Testing Market Categorized By Segments?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass

2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)

3) By Myoglobin: Total Myoglobin

4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

5) By Ischemia Modified Albumin (IMA): IMA Levels

6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2

What Long-Term Trends Are Likely To Affect The Cardiac Biomarkers Testing Market?

Key players in the cardiac biomarker testing market are leveraging strategic alliances to offer technology that can detect early symptoms of heart problems and enhance patient recovery. These strategic collaborations in the realm of cardiac biomarker testing create a conducive environment for the companies to develop cutting-edge diagnostics, increase their market penetration, and expedite the provision of state-of-the-art testing solutions for superior cardiovascular management. For example, in September 2024, MediBuddy, a health tech firm based in India that provides a comprehensive program for telehealth services, health management, and assistance with insurance, entered into a partnership with Philips, a conglomerate incorporated in the Netherlands. The objective of this alliance is to improve cardiac health in India by integrating Philips’ HeartPrint technology, which allows for consistent monitoring and risk evaluation of cardiac health. Such progressive strategies equip the MediBuddy platform users with sophisticated tools, promoting active handling of heart health and yielding improved outcomes.

Which Firms Are Considered Leaders In The Cardiac Biomarkers Testing Market Space?

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

What Role Do Regional Policies And Investments Play In Cardiac Biomarkers Testing Market Expansion?

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model